AMBOSS closes € 240 million round with international investors

Berlin — AMBOSS has comple­ted its trans­for­ma­tion into a Euro­pean Company (SE) and closed a €240 million finan­cing round with the new main inves­tors KIRKBI, M&G Invest­ments and Light­rock with the parti­ci­pa­tion of exis­ting share­hol­ders. — The exis­ting share­hol­ders Project A Ventures, Partech, Burda Prin­ci­pal Invest­ments (BPI) and Quadrille Capi­tal recei­ved compre­hen­sive legal advice from YPOG in connec­tion with the €240 million finan­cing round. 

The health and EdTech company AMBOSS, foun­ded in Berlin in 2012 by Sievert Weiss, Madjid Salimi, Nawid Salimi and Bene­dikt Hoch­kir­chen, is revo­lu­tio­ni­zing the trans­fer of medi­cal know­ledge. The plat­form combi­nes lear­ning soft­ware and refe­rence work for doctors — from univer­sity to specia­list exams. With up-to-date know­ledge in a matter of seconds, AMBOSS supports effi­ci­ent, evidence-based health­care. Over one million users world­wide rely on the company. 

In 2024, AMBOSS, which was recently conver­ted into a Euro­pean Company (SE), acqui­red Nova­heal, a start-up in the care sector, and NEJM Know­ledge+, an exam prepa­ra­tion product for medi­cal resi­dents in the USA. The inter­na­tio­nal team has now grown to over 400 doctors, scien­tists and soft­ware deve­lo­pers with offices in Colo­gne, Berlin and New York. 

Streng­thening the next gene­ra­tion of health­care professionals

Over 1 million users in more than 180 count­ries trust AMBOSS for clini­cal decis­­ion-making and medi­cal educa­tion. Every second inpa­ti­ent treat­ment in Germany is perfor­med by a physi­cian supported by AMBOSS. In the USA, the majo­rity of medi­cal students use AMBOSS to successfully prepare for exams and achieve better results than with other ques­ti­on­n­aires. 25% of Ameri­can first-year resi­dents rely on AMBOSS to provide excel­lent pati­ent care. The concept is as simple as it is successful: medi­cal experts distill rele­vant medi­cal know­ledge, and AI-powered tech­no­logy makes it directly available to users. 

Peter Bason (photo), Head of Private Capi­tal at KIRKBI (Lego family), says: “We have follo­wed the impres­sive growth of AMBOSS, from its successful expan­sion in the US to its strong focus on inno­va­tion. AMBOSS’ unique plat­form is beco­ming an indis­pensable tool for both medi­cal students and health­care profes­sio­nals, support­ing lear­ning and decis­ion making at every stage.” 

The inves­tors’ support will prima­rily be used to open up further inter­na­tio­nal markets and to expand the range of services for nursing staff and other health­care professionals.

In addi­tion, the latest finan­cing round signi­fi­cantly impro­ves access to capi­tal for AMBOSS.

Advi­sor to the follo­wing inves­tors: YPOG 

Project A Ventures

Dr. Martin Scha­per (Lead, Tran­sac­tions), Part­ner, Berlin; Ciro D’Ame­lio (Tran­sac­tions), Senior Asso­ciate, Berlin

Consultant:inside Partech

Dr. Tim Schlös­ser (Lead, Tran­sac­tions), Part­ner, Berlin; Pia Meven (Tran­sac­tions), Asso­cia­ted Part­ner, Berlin; Barbara Hasse (Tran­sac­tions), Senior Asso­ciate, Berlin

Advisors:inside Burda Prin­ci­pal Invest­ments and Quadrille Capital

Dr. Benja­min Ullrich (Co-Lead, Tran­sac­tions), Part­ner, Berlin; Tobias Lovett (Co-Lead, Tran­sac­tions), Asso­cia­ted Part­ner, Berlin; Dr. Stephan Bank (Funds/ Tran­sac­tions), Part­ner, Berlin; Farina Weber (Tran­sac­tions), Asso­ciate, Berlin.

About AMBOSS

Foun­ded in 2012 by a team of physi­ci­ans, AMBOSS is a global medi­cal know­ledge plat­form that has funda­men­tally chan­ged the way medi­cal know­ledge is acqui­red and used at the point of care. With a focus on accu­rate, high-quality content, inno­va­tive AI-powered tech­no­logy and a user-cente­­red approach, the company has grown its inter­na­tio­nal team to over 500 employees from more than 50 count­ries, inclu­ding scien­tists, soft­ware engi­neers and more than 150 physi­ci­ans. AMBOSS has more than 1 million profes­sio­nal users in 180 countries.
www.amboss.com.

About Partech

Partech is a global tech invest­ment firm head­quar­te­red in Paris with offices in Berlin, Dakar, Dubai, Nairobi and San Fran­cisco. Partech brings toge­ther capi­tal, opera­tio­nal expe­ri­ence and stra­te­gic support to help entre­pre­neurs from seed to growth stage. Foun­ded 40 years ago in San Fran­cisco, the company today mana­ges €2.5 billion in assets and a current port­fo­lio of 220 compa­nies in 40 count­ries and on 4 continents. 

About Burda Prin­ci­pal Investments

Burda Prin­ci­pal Invest­ments (BPI) is a leading inter­na­tio­nal growth capi­tal provi­der with offices in London, Munich, Berlin and Singa­pore. As a divi­sion of Hubert Burda Media, BPI part­ners with visio­nary entre­pre­neurs and supports them with Burda’s capi­tal, brands and indus­try exper­tise — parti­cu­larly in the areas of busi­ness expan­sion, inter­na­tio­na­liza­tion and loca­liza­tion. BPI’s port­fo­lio includes nume­rous successful and fast-growing compa­nies in Europe, the USA and Asia, inclu­ding Nord Secu­rity, Vinted, Aleph Alpha, Bloom and Wild, Money­box, Skills­hare, Expel, Carsome and BillEase. 

About Quadrille Capital

Quadrille is a trans­at­lan­tic invest­ment plat­form with a focus on high-growth tech­no­logy compa­nies. For over 25 years, Quadrille has supported successful growth-stage compa­nies in Europe, the US and Asia. In addi­tion, the company invests in comple­men­tary private secon­dary and primary stra­te­gies in the tech­no­logy sector and has €1.8 billion in assets under manage­ment. The team consists of 40 profes­sio­nals based in Paris, New York and San Francisco.